Enzyme Entrapment in Erythrocytes and Liposomes for the Treatment of Lysosomal Storage Diseases

No abstract is available for this paper.

• Publication year

  1977

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1007/978-1-4684-2610-6_16
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• The role of surface carbohydrates in the hepatic recognition and transport of circulating glycoproteins.

  2006cited by this paper
• [115] Ceramide trihexosidase from human placenta

  1978cited by this paper
• Toward enzyme therapy for lysosomal storage diseases.

  1976cited by this paper
• A general method for the introduction of enzymes, by means of immunoglobulin-coated liposomes, into lysosomes of deficient cells.

  1975cited by this paper
• Immune response to liposomal model membranes: restricted IgM and IgG anti-dinitrophenyl antibodies produced in guinea pigs.

  1975cited by this paper
• Placental acid hydrolase purification on concanavalin A-sepharose.

  1975cited by this paper
• The prevention of genetic disease and mental retardation

  1975cited by this paper
• Enzyme Therapy. V. In Vivo Fate of Erythrocyte-entrapped β-Glucuronidase in β-Glucuronidase-deficient mice

  1975cited by this paper
• Binding of human liver beta-galactosidases to plant lectins insolubilized on agarose.

  1974cited by this paper
• Replacement therapy for inherited enzyme deficiency. Use of purified glucocerebrosidase in Gaucher's disease.

  1974cited by this paper
• Enzyme therapy IV: A method for determining the In Vivo fate of bovine β-glucuronidase in β-glucuronidase deficient mice

  1974cited by this paper
• Entrapment of proteins in liposomes prevents allergic reactions in pre‐immunised mice

  1974cited by this paper
• In vitro correction of deficient human fibroblasts by beta-glucuronidase from different human sources.

  1974cited by this paper
• Quantitative aspects of pinocytosis and the intracellular fate of N-acetyl-alpha-D-glucosaminidase in Sanfilippo B fibroblasts.

  1974cited by this paper
• Enzyme therapy. II. Purified human alpha-galactosidase A. Stabilization to heat and protease degradation by complexing with antibody and by chemical modification.

  1974cited by this paper
• Liposomes as immunological adjuvants

  1974cited by this paper
• Differential uptake of human beta-glucuronidase isoenzymes from spleen by deficient fibroblasts.

  1974cited by this paper
• Hypotonic exchange loading of human erythrocytes with 59Fe-labeled rabbit hemoglobin

  1974cited by this paper
• Immobilization of enzymes, adsorbents, or both within semipermeable microcapsules (artificial cells) for clinical and experimental treatment of metabolite-related disorders.

  1973cited by this paper
• A -glucuronidase deficiency mucopolysaccharidosis: studies in cultured fibroblasts.

  1973cited by this paper
• Enzyme replacement in Pompe disease: an attempt with purified human acid alpha-glucosidase.

  1973cited by this paper
• Caveat to protein replacement therapy for genetic disease. Immunological implications of accurate molecular diagnosis.

  1973cited by this paper
• Enzyme loading of erythrocytes.

  1973cited by this paper
• Sanfilippo Disease Type B: Enzyme Replacement and Metabolic Correction in Cultured Fibroblasts

  1973cited by this paper
• Chemical modification of enzymes.

  1973cited by this paper
• Replacement therapy for inherited enzyme deficiency. Use of purified ceramidetrihexosidase in Fabry's disease.

  1973cited by this paper
• Intravenous injection of purified hexosaminidase A into a patient with Tay-Sachs disease.

  1973cited by this paper
• Uptake of beta-glucuronidase by deficient human fibroblasts.

  1973cited by this paper
• Preparation and properties of an affinity column adsorbent for differentiation of multiple forms of -galactosidase activity.

  1973cited by this paper
• The defect in the Hurler and Scheie syndromes: deficiency of -L-iduronidase.

  1972cited by this paper
• Fate of protein-containing liposomes injected into rats. An approach to the treatment of storage diseases.

  1972cited by this paper
• Enzyme entrapment in liposomes

  1971cited by this paper
• Correction of Abnormal Cerebroside Sulfate Metabolism in Cultured Metachromatic Leukodystrophy Fibroblasts

  1971cited by this paper
• Incorporation of lysozyme into liposomes. A model for structure-linked latency.

  1970cited by this paper
• FROM CYTASES TO LYSOSOMES.

  1964cited by this paper
• Effects of sulfhydryl inhibition on red blood cells. II. Studies in vivo.

  1962cited by this paper

• Advances in Human Genetics 11

  2013cites this paper
• Immobilised enzymes as drugs

  1987cites this paper
• Advances in the treatment of inherited metabolic diseases.

  1981cites this paper
• The modern state and prospects for the use of immobilized physiologically active protein substances in medicine (survey)

  1980cites this paper